Nucleic acid drugs—current status, issues, and expectations for exosomes
Y Yamada - Cancers, 2021 - mdpi.com
Simple Summary Nucleic acid drugs provide novel therapeutic modalities with
characteristics that differ from those of small molecules and antibodies. In this review, I focus …
characteristics that differ from those of small molecules and antibodies. In this review, I focus …
Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy
H Zhao, J Wei, J Sun - International Immunopharmacology, 2020 - Elsevier
Transforming growth factor β (TGF-β) signaling pathway has pleiotropic effects on cell
proliferation, differentiation, adhesion, senescence, and apoptosis. TGF-β can be widely …
proliferation, differentiation, adhesion, senescence, and apoptosis. TGF-β can be widely …
Temozolomide for high grade glioma
Background High grade glioma (HGG) is an aggressive form of brain cancer. Treatment of
HGG usually entails biopsy, or resection if safe, followed by radiotherapy. Temozolomide is …
HGG usually entails biopsy, or resection if safe, followed by radiotherapy. Temozolomide is …
Immune escape in glioblastoma multiforme and the adaptation of immunotherapies for treatment
JRD Pearson, S Cuzzubbo, S McArthur… - Frontiers in …, 2020 - frontiersin.org
Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has
a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or …
a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or …
Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites
P Perng, M Lim - Frontiers in oncology, 2015 - frontiersin.org
The central nervous system (CNS) possesses powerful local and global immunosuppressive
capabilities that modulate unwanted inflammatory reactions in nervous tissue. These same …
capabilities that modulate unwanted inflammatory reactions in nervous tissue. These same …
TGF-beta signaling in cancer treatment
I Fabregat, J Fernando, J Mainez… - Current pharmaceutical …, 2014 - ingentaconnect.com
The transforming growth factor-beta (TGF-!) belongs to a superfamily of cytokines that act on
protein kinase receptors at the plasma membrane to induce a plethora of biological signals …
protein kinase receptors at the plasma membrane to induce a plethora of biological signals …
14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2
Transforming growth factor β (TGF-β) functions as a tumor suppressor in premalignant cells
but as a metastasis promoter in cancer cells. The dichotomous functions of TGF-β are …
but as a metastasis promoter in cancer cells. The dichotomous functions of TGF-β are …
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
P Barata, AK Sood, DS Hong - Cancer treatment reviews, 2016 - Elsevier
Recent advances in RNA delivery and target selection provide unprecedented opportunities
for cancer treatment, especially for cancers that are particularly hard to treat with existing …
for cancer treatment, especially for cancers that are particularly hard to treat with existing …
TGF-β signaling in health, disease, and therapeutics
Z Deng, T Fan, C Xiao, H Tian, Y Zheng, C Li… - Signal transduction and …, 2024 - nature.com
Transforming growth factor (TGF)-β is a multifunctional cytokine expressed by almost every
tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular …
tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular …
Transforming growth factor-β in tumour development
CB Trelford, L Dagnino… - Frontiers in Molecular …, 2022 - frontiersin.org
Transforming growth factor-β (TGFβ) is a ubiquitous cytokine essential for embryonic
development and postnatal tissue homeostasis. TGFβ signalling regulates several biological …
development and postnatal tissue homeostasis. TGFβ signalling regulates several biological …